Saccharomyces cerevisiae var. boulardii as a eukaryotic probiotic and its therapeutic functions

Fuller, in 1989, described probiotic microorganisms as “a live microbial feed supplement, which beneficially affects the host animal, by improving its intestinal microbial balance”. Saccharomyces cerevisiae var. boulardii (S.boulardii) is an accurate probiotic yeast idol. The detection and budding of S.boulardiiis firmly related to the impression of healthiness to promote microorganisms from foodstuff. S.boulardiiis similar to S.cerevisiae in that it equally does not have the capability to penetrate into tissues like the Candida species is able to, hence they are not invasive. Some printed medicinal researches have shown the effectiveness and safety of S.boulardii for different illness indications in both adults and children. On the subject of the therapy employed, diverse indications of S.boulardii are as follows: Anticipation of antibiotic related diarrhea, recurring Clostridium difficile related diarrhea and colitis, severe viral and bacterial diarrhea, travelers’ diarrhea, antiinflammatory bowel syndromes as well as Crohnʹs disease and so on. These days, S.boulardii is regularly marketed as a probiotic in a lyophilized shape and is often referred to as S.boulardii lyo.